REFERENCES
Bruning, A. H. L., Leeflang, M. M. G., Vos, J. M. B. W., Spijker, R., de Jong, M. D., Wolthers, K. C., & Pajkrt, D. (2017). Rapid tests for influenza, respiratory syncytial virus, and other respiratory viruses: a systematic review and meta-analysis. Clinical Infectious Diseases , 65 (6), 1026–1032. https://doi.org/1032. doi:10.1093/cid/cix461
CDC. (2003a). CDC Lab Sequences Genome of New Coronavirus. CDC Media Relations Press Release404-639-3286 . /https://www.cdc.gov/media/pressrel/r030414.htm
CDC. (2003b). SARS-Associated Coronavirus (SARS-CoV) Sequencing.Laboratory Testing & Specimens . https://www.cdc.gov/sars/lab/sequence.html
CDC. (2017). Severe Acute Respiratory Syndrome (SARS). National Center for Immunization and Respiratory Diseases, Division of Viral Diseases , 1 (1), 1–3.
CDC. (2020). Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19).Coronavirus Disease 2019 (COVID-19) , 1–3. https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html
Chan, P. K. S., To, W. K., Ng, K. C., Lam, R. K. Y., Ng, T. K., Chan, R. C. W., Wu, A., Yu, W. C., Lee, N., Hui, D. S. C., Lai, S. T., Hon, E. K. L., Li, C. K., Sung, J. J. Y., & Tam, J. S. (2004). Laboratory Diagnosis of SARS. Emerging Infectious Diseases , 10 (5), 825–831. https://doi.org/10.3201/eid1005.030682
Cheng, M. P., Papenburg, J., Desjardins, M., Kanjilal, S., Quach, C., Libman, M., Dittrich, S., Yansouni, C. P. (2020). Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review. Annals of Internal Medicine Logo , 1 (1), 1–10.
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K. & Mulders, D. G. (2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance , 25 (3), 2000045.
David, A.J.T and Steven, H. M. (1996). Medical Microbiology.Coronaviruses (4th ed.). he University of Texas Medical Branch at Galveston. https://www.ncbi.nlm.nih.gov/books/NBK7782/
Dembert, M. L., & Kaiser, C. (1983). Laboratory diagnosis of viral infections. American Family Physician , 28 (4), 125–139. https://doi.org/10.1016/b978-0-12-800946-8.00005-2
ECDC. (2020a). COVID-19 situation update worldwide, as of 8 May 2020.Threats and Outbreaks Situation Update Worldwide . https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases
ECDC. (2020b). Novel coronavirus (SARS-CoV-2) Discharge criteria for confirmed COVID-19 cases – When is it safe to discharge COVID-19 cases from the hospital or end home isolation? ECDC Technical Report , 1–5. https://www.nejm.org/doi/pdf/10.1056/NEJMc2001468?articleTools=true
Elflein, J. (2020). Coronavirus (COVID-19) disease pandemic- Statistics & Facts. Health & Pharmaceuticals›State of Health . https://www.statista.com/topics/5994/the-coronavirus-disease-covid-19-outbreak/
FDA. (2020). Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers, and Food and Drug Administration Staff.Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency , 1 (1), 1–10.
Fuk-Woo, J. C., Yuan, S., Kok, K., Kai-Wang, K.To., Chu, H., Yang, J., Xing, F., Liu, J., Chik-Yan, C.Y., Wing-Shan, R.P., Tsoi, H., Kam-Fai, S.L, Chan, K., Kwok-Man, V.P., Chan, J., DanieL., J.I., Cai, Chi-Chung, V.C., Chen, H., Christopher, K., Yuen, K. (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet, Elseveir Articles , 395 (10229), 1054. www.thelancet.com
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.The Lancet , 395 (10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
Hui, D. S. C., Chan, M. C. H., Wu, A. K., & Ng, P. C. (2004). Severe acute respiratory syndrome (SARS): Epidemiology and clinical features.Postgraduate Medical Journal , 80 (945), 373–381. https://doi.org/10.1136/pgmj.2004.020263
James, N. (2017). Fenner’s veterinary virology. In Elsevier Academic Press. https://doi.org/0.1016/b978-0-12-800946-8.00005-2
Kang, X., Xu, Y., Wu, X., Liang, Y., Wang, C., Guo, J., Wang, Y., Chen, M., Wu, D., Wang, Y., Bi, S., Qiu, Y., Lu, P., Cheng, J., Xiao, B., Hu, L., Gao, X., Liu, J., Wang, Y., … Tang, H. (2005). Proteomic fingerprints for potential application to early diagnosis of severe acute respiratory syndrome. Clinical Chemistry , 51 (1), 56–64. https://doi.org/10.1373/clinchem.2004.032458
Lau, S. K. P., Woo, P. C. Y., Wong, B. H. L., Tsoi, H. W., Woo, G. K. S., Poon, R. W. S., Chan, K. H., Wei, W. I., Malik Peiris, J. S., & Yuen, K. Y. (2004). Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in SARS patients by enzyme-linked immunosorbent assay. Journal of Clinical Microbiology , 42 (7), 2884–2889. https://doi.org/10.1128/JCM.42.7.2884-2889.2004
Leung, D. T. M., Tam, F. C. H., Ma, C. H., Chan, P. K. S., Cheung, J. L. K., Niu, H., Tam, J. S. L., & Lim, P. L. (2004). Antibody Response of Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral Nucleocapsid. The Journal of Infectious Diseases , 190 (2), 379–386. https://doi.org/10.1086/422040
Li, Z., Yi, Y., Luo, X., Xiong, N., Liu, Y., Li, S., Sun, R., Wang, Y., Hu, B., Chen, W., Zhang, Y., Wang, J., Huang, B., Lin, Y., Yang, J., Cai, W., Wang, X., Cheng, J., Chen, Z., … Ye, F. (2020). Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. Journal of Medical Virology , 0–1. https://doi.org/10.1002/jmv.25727
Maschinen, B., Investition, A., Beschaffungen, G., Ersatzbeschaffungen, B., & Mittelherkunft, S. (2005). Distric laboratory practice in tropical countries .
McIntosh, Kenneth., Martin S Hirsch., A. B. (2020). Coronavirus disease 2019 (COVID-19): Epidemiology, virology, clinical features, diagnosis, and prevention. 2020Uptodate , 1 (1). https://www.uptodate.com/contents/coronavirus-disease-2019
NIM. (2020). COVID-19 is an emerging, rapidly evolving situation.National Institute for Allergy and Infectious Diseasdes . https://www.niaid.nih.gov/diseases-conditions/coronaviruses
Okba, N. M. A., Muller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., Bruin, E. de, Chandler, F. D., Yazdanpanah, Y., Hingrat, Q. Le, Descamps, D., Houhou-Fidouh, N., Reusken, C. B. E. M., Bosch, B.-J., Drosten, C., Koopmans, M. P. G., & Haagmans, B. L. (2020). SARS-CoV-2 specific antibody responses in COVID-19 patients. MedRxiv , 2020.03.18.20038059. https://doi.org/10.1101/2020.03.18.20038059
Reller, L. B., & Weinstein, M. P. (2000). Special section: Medical microbiology. Clinical Infectious Diseases , 30 (5), 798. https://doi.org/10.1086/313790
Ren, Y., He, Q. Y., Fan, J., Jones, B., Zhou, Y., Xie, Y., Cheung, C. Y., Wu, A., Chiu, J. F., Peiris, J. S. M., & Tam, P. K. H. (2004). The use of proteomics in the discovery of serum biomarkers from patients with severe acute respiratory syndrome. Proteomics , 4 (11), 3477–3484. https://doi.org/10.1002/pmic.200400897
Roos, R. (2003). WHO cites limitations of SARS diagnostic tests.Center for Infectious Diseases and Polycies , 1 (1).
Sampathkumar, P., Temesgen, Z., Smith, T. F., & Thompson, R. L. (2003). SARS: Epidemiology, clinical presentation, management, and infection control measures. Mayo Clinic Proceedings , 78 (7), 882–890. https://doi.org/10.4065/78.7.882
Sheridan, C. (2020). Fast, portable tests come online to curb coronavirus pandemic. Naturenature Biotechnologynewsarticle a Nature Research Journal , 2020 (1–10). https://www.nature.com/articles/d41587-020-00010-2
USFDA. (2020). FAQs on Diagnostic Testing for SARS-CoV-2. An Official Website of the United States Governmen , 1–2. https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs
Vashist, S. K. (2017). Point-of-care diagnostics: Recent advances and trends. Biosensors , 7 (4), 10–13. https://doi.org/10.3390/bios7040062
Wadsworth, N. (2003). Laboratory Diagnosis of SARS . 1–13. https://www.health.ny.gov/diseases/communicable/sars
WHO. (2003). Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). Consensus Document on the Epidemiology of Severe Acute Respiratory Syndrome (SARS) , 1–47. https://www.who.int/csr/sars/en/WHOconsensus.pdf
WHO. (2020). Coronavirus disease (COVID-19) Pandemic. Coronavirus Disease 2019 . https://www.who.int/emergencies/diseases/novel-coronavirus-2019?
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., Song, J., Wang, S., Chao, Y., Yang, Z., Xu, J., Zhou, X., Chen, D., Xiong, W., Xu, L., Zhou, F., Jiang, J., Ba, i C., Zheng, J., Song, Y. (2020). Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. ,2020 . oi: 10.1001/jamainternmed.2020.0994.
Xu, X. (2020). SARS-CoV-2 (2019-nCoV) Antigen Reagents. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission . https://www.sinobiological.com/research/virus/2019-ncov-antigen
Ying, L., Yue-ping, L., Bo, D., Feifei, R., Yue, W., Jinya, D., Qianchuan, H., Hospital, G., Command, C. T., Hospital, G., & Theater, C. (2020). Diagnostic Indexes of a Rapid IgG/IgM Combined Antibody Test for SARS-CoV-2 . 1–14.
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., Qian, S., Hong, C., Wang, F., Liu, Y., Wang, Z., He, Q., Li, Z., He, B., Zhang, T., … Zhang, Z. (2020). Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019.Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America . https://doi.org/10.1093/cid/ciaa344